Advertisement

miR-129-5p Alleviates Neuropathic Pain Through Regulating HMGB1 Expression in CCI Rat Models

  • Jun Tian
  • Tieying SongEmail author
  • Wenli Wang
  • Hong Wang
  • Zaiwang Zhang
Article
  • 33 Downloads

Abstract

Recently, microRNAs are reported to be participated in the development of pain and persistence of neuropathic and inflammatory pain in animal models. Here, we characterized the functional role of miR-129-5p in pain processing in chronic constriction injury (CCI) rat models. Bilateral CCI operation was used to generate neuropathic pain rat model. Paw withdrawal threshold (PWT) and paw withdrawal latency (PWL) were used to assess pain-related behaviors. Gene expression was evaluated using qRT-PCR, luciferase assay, western blotting, and enzyme-linked immunosorbent assay. Compared with the control rats, expression level of miR-129-5p was downregulated significantly over time in CCI rats post operation. Interestingly, downregulation of miR-129-5p in CCI rats was correlated with increased proinflammatory cytokine expression and pain-related behaviors. Furthermore, we found that miR-129-5p alleviated neuropathic pain through downregulating high mobility group protein B1 (HMGB1) expression in CCI rats as overexpression of miR-129-5p suppressed expression of both HMGB1 and proinflammatory cytokine and alleviated pain sensation in CCI rats. In summary, our results show that alteration in miR-129-5p expression contributes to pain processing in our CCI pain rat model, suggesting miR-129-5p could be a causal factor in neuropathic pain and serve as a promising potential biomarker and therapeutic target for neuropathic pain.

Keywords

miR-129-5p Neuropathic pain HMGB1 Cytokines CCI rat models 

Notes

Funding Information

The study was supported by the Hebei Province Natural Fund Surface Project (H2017106022).

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. Agalave NM, Svensson CI (2015) Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain. Mol Med 20:569–578.  https://doi.org/10.2119/molmed.2014.00176 CrossRefGoogle Scholar
  2. Attal N (2000) Chronic neuropathic pain: mechanisms and treatment. Clin J Pain 16:S118–S130CrossRefGoogle Scholar
  3. Bai G, Ambalavanar R, Wei D, Dessem D (2007) Downregulation of selective microRNAs in trigeminal ganglion neurons following inflammatory muscle pain. Mol Pain 3:15.  https://doi.org/10.1186/1744-8069-3-15 CrossRefGoogle Scholar
  4. Bali KK, Hackenberg M, Lubin A, Kuner R, Devor M (2014) Sources of individual variability: miRNAs that predispose to neuropathic pain identified using genome-wide sequencing. Mol Pain 10:22.  https://doi.org/10.1186/1744-8069-10-22 CrossRefGoogle Scholar
  5. Bao Y, Wang S, Xie Y, Jin K, Bai Y, Shan S (2018) MiR-28-5p relieves neuropathic pain by targeting Zeb1 in CCI rat models. J Cell Biochem 119:8555–8563.  https://doi.org/10.1002/jcb.27096 CrossRefGoogle Scholar
  6. Blom SM, Pfister JP, Santello M, Senn W, Nevian T (2014) Nerve injury-induced neuropathic pain causes disinhibition of the anterior cingulate cortex. J Neurosci 34:5754–5764.  https://doi.org/10.1523/JNEUROSCI.3667-13.2014 CrossRefGoogle Scholar
  7. Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C (2008) Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136:380–387.  https://doi.org/10.1016/j.pain.2007.08.013 CrossRefGoogle Scholar
  8. Clark AK, Old EA, Malcangio M (2013) Neuropathic pain and cytokines: current perspectives. J Pain Res 6:803–814.  https://doi.org/10.2147/JPR.S53660 Google Scholar
  9. Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, Freeman R, Truini A, Attal N, Finnerup NB, Eccleston C, Kalso E, Bennett DL, Dworkin RH, Raja SN (2017) Neuropathic pain. Nat Rev Dis Primers 3:17002.  https://doi.org/10.1038/nrdp.2017.2 CrossRefGoogle Scholar
  10. Colvin LA, Dougherty PM (2015) Peripheral neuropathic pain: signs, symptoms, mechanisms, and causes: are they linked? Br J Anaesth 114:361–363.  https://doi.org/10.1093/bja/aeu323 CrossRefGoogle Scholar
  11. Dai Z, Chu H, Ma J, Yan Y, Zhang X, Liang Y (2018) The regulatory mechanisms and therapeutic potential of microRNAs: from chronic pain to morphine tolerance. Front Mol Neurosci 11:80.  https://doi.org/10.3389/fnmol.2018.00080 CrossRefGoogle Scholar
  12. DeLeo JA, Colburn RW, Nichols M, Malhotra A (1996) Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J Interf Cytokine Res 16:695–700.  https://doi.org/10.1089/jir.1996.16.695 CrossRefGoogle Scholar
  13. Doyen PJ, Vergouts M, Pochet A, Desmet N, van Neerven S, Brook G, Hermans E (2017) Inflammation-associated regulation of RGS in astrocytes and putative implication in neuropathic pain. J Neuroinflammation 14:209.  https://doi.org/10.1186/s12974-017-0971-x CrossRefGoogle Scholar
  14. Genda Y, Arai M, Ishikawa M, Tanaka S, Okabe T, Sakamoto A (2013) microRNA changes in the dorsal horn of the spinal cord of rats with chronic constriction injury: a TaqMan(R) Low Density Array study. Int J Mol Med 31:129–137.  https://doi.org/10.3892/ijmm.2012.1163 CrossRefGoogle Scholar
  15. Hung AL, Lim M, Doshi TL (2017) Targeting cytokines for treatment of neuropathic pain. Scand J Pain 17:287–293.  https://doi.org/10.1016/j.sjpain.2017.08.002 CrossRefGoogle Scholar
  16. Janssens R, Struyf S, Proost P (2018) The unique structural and functional features of CXCL12. Cell Mol Immunol 15:299–311.  https://doi.org/10.1038/cmi.2017.107 CrossRefGoogle Scholar
  17. Jiangpan P, Qingsheng M, Zhiwen Y, Tao Z (2016) Emerging role of microRNA in neuropathic pain. Curr Drug Metab 17:336–344CrossRefGoogle Scholar
  18. McCarberg BH, Billington R (2006) Consequences of neuropathic pain: quality-of-life issues and associated costs. Am J Manag Care 12:S263–S268Google Scholar
  19. Tang S, Zhou J, Jing H, Liao M, Lin S, Huang Z, Huang T, Zhong J, HanbingWang (2019) Functional roles of lncRNAs and its potential mechanisms in neuropathic pain. Clin Epigenetics 11:78.  https://doi.org/10.1186/s13148-019-0671-8 CrossRefGoogle Scholar
  20. von Schack D, Agostino MJ, Murray BS, Li Y, Reddy PS, Chen J, Choe SE, Strassle BW, Li C, Bates B, Zhang L, Hu H, Kotnis S, Bingham B, Liu W, Whiteside GT, Samad TA, Kennedy JD, Ajit SK (2011) Dynamic changes in the microRNA expression profile reveal multiple regulatory mechanisms in the spinal nerve ligation model of neuropathic pain. PLoS One 6:e17670.  https://doi.org/10.1371/journal.pone.0017670 CrossRefGoogle Scholar
  21. Wei W, Wang H, Ji S (2017) Paradoxes of the EphB1 receptor in malignant brain tumors. Cancer Cell Int 17:21.  https://doi.org/10.1186/s12935-017-0384-z CrossRefGoogle Scholar
  22. Xie X, Ma L, Xi K, Zhang W, Fan D (2017) MicroRNA-183 suppresses neuropathic pain and expression of AMPA receptors by targeting mTOR/VEGF signaling pathway. Cell Physiol Biochem 41:181–192.  https://doi.org/10.1159/000455987 CrossRefGoogle Scholar
  23. Yang D et al (2017) The role of miR-190a-5p contributes to diabetic neuropathic pain via targeting SLC17A6. J Pain Res 10:2395–2403.  https://doi.org/10.2147/JPR.S133755 CrossRefGoogle Scholar
  24. Yu SN, Liu GF, Li LY, Zhao GQ, Liu L, Li XF (2019) Analgesic effects of microRNA-129-5p against bone cancer pain through the EphB1/EphrinB2 signaling pathway in mice. J Cell Biochem 120:2876–2885.  https://doi.org/10.1002/jcb.26605 CrossRefGoogle Scholar
  25. Zempleni J, Baier SR, Howard KM, Cui J (2015) Gene regulation by dietary microRNAs. Can J Physiol Pharmacol 93:1097–1102.  https://doi.org/10.1139/cjpp-2014-0392 CrossRefGoogle Scholar
  26. Zeng J, Shen JP, Wang JT, Hu HW, Zhang CJ, Bai R, Zhang LM, He JZ (2018) Impacts of projected climate warming and wetting on soil microbial communities in Alpine grassland ecosystems of the Tibetan Plateau. Microb Ecol 75:1009–1023.  https://doi.org/10.1007/s00248-017-1098-4 CrossRefGoogle Scholar
  27. Zhang JM, An J (2007) Cytokines, inflammation, and pain. Int Anesthesiol Clin 45:27–37.  https://doi.org/10.1097/AIA.0b013e318034194e CrossRefGoogle Scholar
  28. Zhang J, Zhang H, Zi T (2015) Overexpression of microRNA-141 relieves chronic constriction injury-induced neuropathic pain via targeting high-mobility group box 1. Int J Mol Med 36:1433–1439.  https://doi.org/10.3892/ijmm.2015.2342 CrossRefGoogle Scholar
  29. Zhang Y, Huang B, Wang HY, Chang A, Zheng XFS (2017) Emerging role of microRNAs in mTOR signaling. Cell Mol Life Sci 74:2613–2625.  https://doi.org/10.1007/s00018-017-2485-1 CrossRefGoogle Scholar
  30. Zhou Y, Ferguson J, Chang JT, Kluger Y (2007) Inter- and intra-combinatorial regulation by transcription factors and microRNAs. BMC Genomics 8:396.  https://doi.org/10.1186/1471-2164-8-396 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Neurosurgerythe First Hospital of ShijiazhuangShijiazhuangChina
  2. 2.Department of Anesthesiologythe First Hospital of ShijiazhuangShijiazhuangChina
  3. 3.Department of GynaecologyMaternal and Child Health Care Hospital of ShijiazhuangShijiazhuangChina
  4. 4.Department of Anesthesiologythe Bethune International Peace Hospital of P.L.AShijiazhuangChina

Personalised recommendations